Literature DB >> 16126126

Prevalence and risk factors for erectile dysfunction in Japanese diabetics.

Hideyuki Sasaki1, Hiroshi Yamasaki, Kenichi Ogawa, Kishio Nanjo, Ryuzo Kawamori, Yasuhiko Iwamoto, Shigehiro Katayama, Masafumi Shirai.   

Abstract

We evaluated the prevalence and risk factors for erectile dysfunction (ED) and interest in ED treatment among Japanese men being treated for type 2 diabetes mellitus. Patients (40-79 years; n=1118) completed the 5-item version of the International Index of Erectile Function (IIEF-5), and questions related to interest in ED pharmacotherapy, subjective symptoms of diabetes, and general quality of life. A separate survey completed by physicians examined the relationships between age, diabetic treatments (insulin or oral), symptoms of diabetes (poor glycemic control, microangiopathy), complications of diabetes (hypertension, ischemic heart disease, cerebrovascular disease), and ED. The prevalence of ED in patients with diabetes was 90%, a rate double that of non-diabetic individuals. Multivariate analyses revealed that age, insulin therapy, microangiopathy, hypertension, history of cerebrovascular or cardiovascular disease, leg dysesthesia, dysuria, insomnia, and anorexia all represented significant risk factors for ED. Half of all respondents were interested (29%) or would consider pharmacotherapy for ED (21%). These findings suggest that ED is a significant problem in Japanese men with diabetes, and that specific risk factors increase the prevalence of ED. Furthermore, the survey results expose national attitudes toward treatment of ED.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16126126     DOI: 10.1016/j.diabres.2005.02.018

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  21 in total

1.  Assessment of erectile dysfunction and associated psychological distress in Chinese men with type 2 diabetes mellitus.

Authors:  S Chen; D Peng; X Xu; J Gao; F Dai; C Zuo; Q Zhang
Journal:  Int J Impot Res       Date:  2017-06-29       Impact factor: 2.896

2.  Diabetic peripheral neuropathy and prevalence of erectile dysfunction in Japanese patients aged <65 years with type 2 diabetes mellitus: The Dogo Study.

Authors:  S Furukawa; T Sakai; T Niiya; H Miyaoka; T Miyake; S Yamamoto; K Maruyama; T Ueda; H Senba; Y Todo; M Torisu; H Minami; M Onji; T Tanigawa; B Matsuura; Y Hiasa; Y Miyake
Journal:  Int J Impot Res       Date:  2016-10-27       Impact factor: 2.896

3.  Circulating endothelial progenitor cells in type 1 diabetic patients with erectile dysfunction.

Authors:  Maria Ida Maiorino; Giuseppe Bellastella; Michela Petrizzo; Elisabetta Della Volpe; Rosanna Orlando; Dario Giugliano; Katherine Esposito
Journal:  Endocrine       Date:  2014-11-20       Impact factor: 3.633

4.  Plant-based diet index and erectile dysfunction in the Health Professionals Follow-Up Study.

Authors:  Heiko Yang; Benjamin N Breyer; Eric B Rimm; Edward Giovannucci; Stacy Loeb; Stacey A Kenfield; Scott R Bauer
Journal:  BJU Int       Date:  2022-06-09       Impact factor: 5.969

5.  Association between erectile dysfunction and cardiovascular risk in individuals with type-2 diabetes without overt cardiovascular disease.

Authors:  Babu Lal Meena; Dhanpat Kumar Kochar; Tulsi Das Agarwal; Raghvendra Choudhary; Abhishek Kochar
Journal:  Int J Diabetes Dev Ctries       Date:  2009-10

6.  Erectile dysfunction and cardiovascular events in diabetic men: a meta-analysis of observational studies.

Authors:  Tomohide Yamada; Kazuo Hara; Hitomi Umematsu; Ryo Suzuki; Takashi Kadowaki
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

7.  Independent Predictors of Erectile Dysfunction in Type 2 Diabetes Mellitus: Is It True What They Say about Risk Factors?

Authors:  Faranak Sharifi; Mohammad Asghari; Yahya Jaberi; Oveis Salehi; Fatemeh Mirzamohammadi
Journal:  ISRN Endocrinol       Date:  2012-08-27

Review 8.  Phosphodiesterase-5 inhibitors for erectile dysfunction in patients with diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Yatan Pal Singh Balhara; Siddharth Sarkar; Rishab Gupta
Journal:  Indian J Endocrinol Metab       Date:  2015 Jul-Aug

Review 9.  Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence.

Authors:  Antonio Martín Morales; Vincenzo Mirone; John Dean; Pierre Costa
Journal:  Clin Interv Aging       Date:  2009-12-29       Impact factor: 4.458

10.  The evaluation of sexual dysfunction in male patients with migraine and tension type headache.

Authors:  Durdane Aksoy; Volkan Solmaz; Betul Cevik; Yusuf Gencten; Fikret Erdemir; Semiha Gulsum Kurt
Journal:  J Headache Pain       Date:  2013-05-29       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.